静脈栄養の市場規模、シェア、動向分析レポート：栄養タイプ別、段階タイプ別、適応症別、販売チャネル別、地域別、セグメント予測、2024年～2030年

静脈栄養市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の静脈栄養市場規模は2030年までに106億8,000万米ドルに達し、2024年から2030年までのCAGRは6.01％を記録すると予測されています。

栄養不良の有病率の増加、代謝性疾患の増加、老人人口の増加、ヘルスケアインフラの進歩は、市場成長を促進する要因の一部です。高齢者人口の増加は、静脈栄養（PN）需要の増加に大きく寄与しています。例えば、人口問題研究所（PRB）によると、米国の65歳以上の人口は2022年の5,800万人から2050年には8,200万人に増加すると予想されています。

免疫力が低く、神経疾患、心血管疾患、がん、脊椎損傷にかかりやすい老年人口が大量に存在することは、市場促進要因としてインパクトが大きいです。さらに、重症患者における必須栄養不足の急増や、病院関連の栄養失調に対する意識の高まりは、PNの採用を増加させるいくつかの重要な要因です。非経口的薬剤投与は、即効性と低用量デリバリーという利点を提供し、食事の不均衡によるさまざまな副作用を防ぐため、市場の成長を促進します。しかし、投与中の感染リスクが高いことや、患者の間で静脈栄養への嗜好が高まっていることが、市場成長を抑制する主な要因となっています。世界の人口増加により、ヘルスケアコストと家庭の食費が増加しています。

したがって、出生率の上昇が栄養水準に影響を与え、それによって市場の成長が促進されると予想されます。国連の統計によると、世界人口は2022年の80億人から2050年には97億人、2080年代半ばには104億人に増加すると予想されています。この人口増加は、栄養成分の希少性を高め、市場成長を促進する可能性があります。実現出生率は、出生1人当たりの水、食糧、投薬の必要量など、環境だけでなく資源の圧力も含まれるため、絶対出生率（粗出生率）よりも重要な役割を果たします。実現出生率は過去10年間で増加しており、この傾向は予測期間中も続くと予想されます。2020年、全米保健統計センター（NCHS）が報告した出生率は、人口1,000人当たり11.99人でした。さらに、低体重児の割合は8.0%であり、それによってPN製品に対する需要が世界中で高まっています。

静脈栄養市場のレポートハイライト

栄養タイプに基づき、市場は炭水化物、非経口脂質エマルション、単回投与アミノ酸溶液、微量元素、ビタミン＆ミネラルに区分されます。単回投与アミノ酸セグメントは、すべての年齢層に適合し、他のタイプの静脈栄養に比べて副作用が少ないことから、2023年に30.7%の最大売上シェアを占めました。

ステージ別では、高齢者人口ががん、糖尿病、アルツハイマー病などのさまざまな慢性疾患に対して脆弱であるため、成人向け市場が2023年に87.1%の売上シェアを占めました。

施設販売チャネルは、2023年に48.1%の最大売上シェアで市場を独占しました。一方、オンラインチャネルは予測期間中に最も速い成長率を示すと予測されています。

2023年には、北米が41.5%の最大売上シェアを占め、アジア太平洋はヘルスケア支出の増加、ヘルスケアインフラの改善、一人当たり所得の増加、早産の多発により、最も速い成長が見込まれる

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 静脈栄養市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場見通し
• 業界分析
  • ユーザーの視点分析
  • 主なエンドユーザー
• テクノロジー展望
• 規制の枠組み
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 業界の課題と機会の分析
• 静脈栄養市場分析ツール
  • ポーターの分析
  • PESTEL分析
• 静脈栄養業界における主要取引と戦略的提携の分析
• COVID-19の影響

第4章 静脈栄養市場：栄養タイプの推定・動向分析

• 定義と範囲
• 栄養タイプの市場シェア分析、2023年および2030年
• セグメントダッシュボード
• 静脈栄養市場：栄養タイプ別、2018～2030年
• 炭水化物
• 非経口脂質乳剤
• 単回投与アミノ酸溶液
• 微量元素
• ビタミンとミネラル

第5章 静脈栄養市場：段階タイプの推定・動向分析

• 定義と範囲
• 段階タイプの市場シェア分析、2023年および2030年
• セグメントダッシュボード
• 静脈栄養市場：段階タイプ別、2018～2030年
• 成人
• 小児

第6章 静脈栄養市場：適応症の推定・動向分析

• 定義と範囲
• 適応症の市場シェア分析、2023年および2030年
• セグメントダッシュボード
• 静脈栄養市場：適応症別、2018～2030年
• 小児アルツハイマー病
• 栄養不足
• がん治療
• 糖尿病
• 慢性腎臓病
• 希少疾患
• 嚥下障害
• 疼痛管理
• 吸収不良/胃腸障害/下痢
• その他

第7章 静脈栄養市場：販売チャネルの推定・動向分析

• 定義と範囲
• 販売チャネルの市場シェア分析、2023年および2030年
• セグメントダッシュボード
• 静脈栄養市場：販売チャネル別、2018～2030年
• オンライン
• 小売り
• 業務

第8章 静脈栄養市場：国、栄養素タイプ、段階の種類、適応症、販売チャネル別の地域推定・動向分析

• 定義と範囲
• 地域市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 地域市場のスナップショット
• SWOT分析
• 静脈栄養市場シェア、地域別、2023年および2030年
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東およびアフリカ

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業分類
• 企業の市場シェア分析
• 企業ヒートマップ分析
• 戦略マッピング
  • 拡大
  • 合併と買収
  • パートナーシップとコラボレーション
  • 新製品の発売
  • 研究開発
• 企業プロファイル
  • Baxter
  • Allergan
  • Actavis Inc.
  • Otsuka Pharmaceutical Factory, Inc.
  • Grifols, SA
  • B. Braun Melsungen AG
  • Vifor Pharma
  • Fresenius Kabi AG
  • Sichuan Kelun Pharmaceutical Co., Ltd
  • Pfizer Inc.（Hospira Inc.）

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 North America Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 4 North America Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 5 North America Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 6 North America Parenteral nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Billion)
• Table 7 U.S. Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 8 U.S. Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 9 U.S. Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 10 U.S. Parenteral nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Billion)
• Table 11 Canada Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 12 Canada Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 13 Canada Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 14 Canada Parenteral nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Billion)
• Table 15 Europe Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 16 Europe Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 17 Europe Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 18 Europe Parenteral nutrition market estimates and forecasts by sales channel, 2018 - 2030 (USD Billion)
• Table 19 UK Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 20 UK Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 21 UK Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 22 UK Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 23 Germany Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 24 Germany Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 25 Germany Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 26 Germany Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 27 France Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 28 France Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 29 France Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 30 France Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 31 Italy Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 32 Italy Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 33 Italy Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 34 Italy Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 35 Spain Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 36 Spain Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 37 Spain Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 38 Spain Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 39 Sweden Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 40 Sweden Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 41 Sweden Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 42 Sweden Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 43 Denmark Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 44 Denmark Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 45 Denmark Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 46 Denmark Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 47 Norway Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 48 Norway Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 49 Norway Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 50 Norway Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 51 Asia Pacific Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 52 Asia Pacific Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 53 Asia Pacific Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 54 Asia Pacific Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 55 Japan Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 56 Japan Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 57 Japan Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 58 Japan Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 59 China Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 60 China Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 61 China Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 62 China Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 63 India Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 64 India Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 65 India Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 66 India Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 67 Australia Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 68 Australia Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 69 Australia Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 70 Australia Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 71 South Korea Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 72 South Korea Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 73 South Africa Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 74 South Korea Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 75 Thailand Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 76 Thailand Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 77 Thailand Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 78 Thailand Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 79 Latin America Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 80 Latin America Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 81 Latin America Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 82 Latin America Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 83 Brazil Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 84 Brazil Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 85 Brazil Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 86 Brazil Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 87 Mexico Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 88 Mexico Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 89 Mexico Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 90 Mexico Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 91 Argentina Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 92 Argentina Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 93 Argentina Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 94 Argentina Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 95 MEA Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 96 MEA Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 97 MEA Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 98 MEA Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 99 South Africa Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 100 South Africa Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 101 South Africa Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 102 South Africa Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 103 Saudi Arabia Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 104 Saudi Arabia Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 105 Saudi Arabia Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 106 Saudi Arabia Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 107 UAE Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 108 UAE Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 109 UAE Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 110 UAE Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)
• Table 111 Kuwait Parenteral nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Billion)
• Table 112 Kuwait Parenteral nutrition market estimates and forecasts, by stage type, 2018 - 2030 (USD Billion)
• Table 113 Kuwait Parenteral nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Billion)
• Table 114 Kuwait Parenteral nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Parenteral Nutrition Market Segmentation
• Fig. 2 Information Procurement
• Fig. 3 Data Analysis Models
• Fig. 4 Market Formulation and Validation
• Fig. 5 Data Validating & Publishing
• Fig. 6 Market Snapshot
• Fig. 7 Segment Snapshot (1/2)
• Fig. 8 Segment Snapshot (2/2)
• Fig. 9 Competitive Landscape Snapshot
• Fig. 10 Parenteral Nutrition- Market Size and Growth Prospects (USD Billion)
• Fig. 11 Parenteral Nutrition Market: Industry Value Chain Analysis
• Fig. 12 Parenteral Nutrition Market: Market Dynamics
• Fig. 13 Parenteral Nutrition Market: PORTER's Analysis
• Fig. 14 Parenteral Nutrition Market: PESTEL Analysis
• Fig. 15 Parenteral Nutrition Market Share by Nutrient Type 2023 & 2030 (USD Billion)
• Fig. 16 Parenteral Nutrition Market, by Nutrient Type: Market Share, 2023 & 2030
• Fig. 17 Carbohydrates Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
• Fig. 18 Parenteral Lipid Emulsion Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Single Dose Amino Acid Solution Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Trace Elements Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Vitamins & Minerals Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Parenteral Nutrition Market, by Stage Type: Key Takeaways
• Fig. 23 Parenteral Nutrition Market, by Stage Type: Market Share, 2023 & 2030
• Fig. 24 Adult Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
• Fig. 25 Pediatric Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
• Fig. 26 Parenteral Nutrition Market Share by Indication 2023 & 2030 (USD Billion)
• Fig. 27 Parenteral Nutrition Market, by Indication: Market Share, 2023 & 2030
• Fig. 28 Pediatric's Alzaimers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
• Fig. 29 Nutrition Deficiency Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Cancer Care Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Diabetes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Chronic Kidney Disease Market Estimates & Forecasts, 2018 - 2030 (USD Million
• Fig. 33 Orphan Disease Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Dysphagia Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Pain Management Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Malabsorption/GI.Disorder/Diarrhea Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Parenteral Nutrition Market, by Sales Channel: Key Takeaways
• Fig. 39 Parenteral Nutrition Market, by Sales Channel: Market Share, 2023 & 2030
• Fig. 40 Online Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
• Fig. 41 Retail Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
• Fig. 42 Institutional Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
• Fig. 43 Parenteral Nutrition Market Revenue, by Region, 2023 & 2030 (USD Billion)
• Fig. 44 Regional Marketplace: Key Takeaways
• Fig. 45 Regional Marketplace: Key Takeaways
• Fig. 46 North America Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 47 U.S. Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 48 Canada Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 49 Europe Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 50 UK Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 51 Germany Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 52 France Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 53 ItalyParenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 54 Spain Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 55 Denmark Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 56 Sweden Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 57 Norway Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 58 Asia Pacific Parenteral Nutrition Market Estimates and Forecast, 2018 - 2030 (USD Billion)
• Fig. 59 China Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 60 Japan Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 61 India Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 62 South Korea Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 63 Thailand Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 64 Australia Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 65 Latin America Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 66 Brazil Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 67 Mexico Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 68 Argentina Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 69 MEA Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 70 Saudi Arabia Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 71 UAE Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 72 South Africa Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 73 Kuwait Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• Fig. 74 Key Company Categorization
• Fig. 75 Company Market Positioning
• Fig. 76 Key Company Market Share Analysis, 2023
• Fig. 77 Strategic Framework

Parenteral Nutrition Market Growth & Trends:

The global parenteral nutrition market size is expected to reach USD 10.68 billion by 2030, registering a CAGR of 6.01% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of malnutrition, rising metabolic disorders, growing geriatric population, and advancement in healthcare infrastructure are some of the factors driving the market growth. The rising geriatric population has significantly contributed to the increasing demand for parenteral nutrition (PN) as the elderly population is more vulnerable to several diseases. For instance, according to the Population Reference Bureau (PRB), the population of the U.S. aged above 65 years is expected to increase from 58 million in 2022 to 82 million in 2050.

The presence of a large pool of geriatric population with low immunity levels and susceptibility to neurological diseases, cardiovascular disorders, cancer, and spinal injuries is a high-impact rendering driver of the market. Moreover, a surge in essential nutrition deficiency among critically ill patients; and growing awareness about hospital-related malnutrition are a few key factors increasing PN adoption. Parenteral drug administration provides the benefit of fast action and lower dose delivery, which prevent various adverse effects because of dietary imbalances, thereby promoting market growth. However, the high risk of infection during administration and the growing preference for enteral nutrition among patients are major factors restricting the market growth. The growing population worldwide has increased healthcare costs and household food expenditures.

Hence, a higher birth rate is expected to impact nutrition levels, thereby driving market growth. According to the United Nations statistics, the world population is expected to increase from 8 billion in 2022 to 9.7 billion in 2050 and 10.4 billion by the mid-2080s. This rising population can increase the scarcity of nutritional ingredients, fueling market growth. Realized natality plays a more prominent role than absolute natality (crude birth rate), as it includes environmental as well as resource pressures, such as water, food, and medication requirements per birth. Realized natality has been growing in the last decade and the trend is anticipated to continue over the forecast period. In 2020, the natality rate reported by the National Center for Health Statistics (NCHS) was 11.99 births per 1,000 population. Furthermore, the percentage of lower-weight infants was 8.0%, thereby boosting the demand for PN products worldwide.

key Request a free sample copy or view report summary: Parenteral Nutrition Market Report

Parenteral Nutrition Market Report Highlights:

Based on nutrient type, the market is segmented into carbohydrates, parenteral lipid emulsions, single-dose amino acid solution, trace elements, and vitamins & minerals. The single-dose amino acid segment held the largest revenue share of 30.7% in 2023 owing to its compatibility with all age groups and its lesser adverse effects compared to other types of parenteral nutrition

Based on stage, the adult segment dominated the market with a revenue share of 87.1% in 2023 owing to the vulnerability of the elderly population to various chronic conditions such as cancer, diabetes, and Alzheimer's disease

Institutional sales channel dominated the market with the largest revenue share of 48.1% in 2023. On the other hand, online channels are anticipated to exhibit the fastest growth rate over the forecast period

In 2023, North America held the largest revenue share of 41.5%, while Asia Pacific is expected to witness the fastest growth due to rising healthcare expenditure, improving healthcare infrastructure, growing per capita income, and high occurrence of preterm births

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Nutrition Type Outlook
  • 2.2.2. Stage Type Outlook
  • 2.2.3. Indication Outlook
  • 2.2.4. Sales Channel Outlook
• 2.3. Competitive Insights

Chapter 3. Parenteral Nutrition Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Industry Analysis
  • 3.2.1. User Perspective Analysis
  • 3.2.2. Key End-users
• 3.3. Technology Outlook
• 3.4. Regulatory Framework
• 3.5. Market Dynamics
  • 3.5.1. Market Drivers Analysis
    • 3.5.1.1. Rising geriatric population
    • 3.5.1.2. Increasing natality rate
    • 3.5.1.3. Increasing incidence of cancer
    • 3.5.1.4. Growing number of premature births
    • 3.5.1.5. Increasing risk of malnutrition
  • 3.5.2. Market Restraints Analysis
    • 3.5.2.1. Shortage of parenteral nutrition products
    • 3.5.2.2. High risk of infections
  • 3.5.3. Industry Challenges and Opportunity Analysis
• 3.6. Parenteral Nutrition Market Analysis Tools
  • 3.6.1. Porter's Analysis
    • 3.6.1.1. Bargaining power of the suppliers
    • 3.6.1.2. Bargaining power of the buyers
    • 3.6.1.3. Threats of substitution
    • 3.6.1.4. Threats from new entrants
    • 3.6.1.5. Competitive rivalry
  • 3.6.2. PESTEL Analysis
    • 3.6.2.1. Political landscape
    • 3.6.2.2. Economic and Social landscape
    • 3.6.2.3. Technological landscape
    • 3.6.2.4. Environmental landscape
    • 3.6.2.5. Legal landscape
• 3.7. Major Deals & Strategic Alliances Analysis in the Parenteral Nutrition Industry
• 3.8. Impact of COVID-19

Chapter 4. Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis

• 4.1. Definition and Scope
• 4.2. Nutrient Type Market Share Analysis, 2023 & 2030
• 4.3. Segment Dashboard
• 4.4. Parenteral Nutrition Market: By Nutrient Type, 2018 to 2030
• 4.5. Carbohydrates
  • 4.5.1. Carbohydrates Market Revenue Estimates and Forecasts, 2018 - 2030
• 4.6. Parenteral Lipid Emulsion
  • 4.6.1. Parenteral Lipid Emulsion Market Revenue Estimates and Forecasts, 2018 - 2030
• 4.7. Single Dose Amino Acid Solution
  • 4.7.1. Single Dose Amino Acid Solution Market Revenue Estimates and Forecasts, 2018 - 2030
• 4.8. Trace Elements
  • 4.8.1. Trace Elements Market Revenue Estimates and Forecasts, 2018 - 2030
• 4.9. Vitamins & Minerals
  • 4.9.1. Vitamins & Minerals Market Revenue Estimates and Forecasts, 2018 - 2030

Chapter 5. Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis

• 5.1. Definition and Scope
• 5.2. Stage Type Market Share Analysis, 2023 & 2030
• 5.3. Segment Dashboard
• 5.4. Parenteral Nutrition Market: By Stage Type, 2018 to 2030
• 5.5. Adult
  • 5.5.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.6. Pediatric
  • 5.6.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Parenteral Nutrition Market: Indication Estimates & Trend Analysis

• 6.1. Definition and Scope
• 6.2. Indication Market Share Analysis, 2023 & 2030
• 6.3. Segment Dashboard
• 6.4. Parenteral Nutrition Market: By Indication, 2018 to 2030
• 6.5. Pediatrics Alzheimer's
  • 6.5.1. Alzheimer's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.6. Nutrition Deficiency
  • 6.6.1. Nutrition Deficiency Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.7. Cancer Care
  • 6.7.1. Cancer Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.8. Diabetes
  • 6.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.9. Chronic Kidney Disease
  • 6.9.1. Chronic Kidney Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.10. Orphan Diseases
  • 6.10.1. Orphan Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.11. Dysphagia
  • 6.11.1. Dysphagia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.12. Pain Management
  • 6.12.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.13. Malabsorption/GI.Disorder/Diarrhea
  • 6.13.1. Malabsorption/GI.Disorder/Diarrhea Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.14. Others
  • 6.14.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis

• 7.1. Definition and Scope
• 7.2. Sales Channel Market Share Analysis, 2023 & 2030
• 7.3. Segment Dashboard
• 7.4. Parenteral Nutrition Market: By Sales Channel, 2018 to 2030
• 7.5. Online
  • 7.5.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.6. Retail
  • 7.6.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.7. Institutional
  • 7.7.1. Institutional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Parenteral Nutrition Market: Regional Estimates & Trend Analysis by Country, Nutrient Type, Stage Type, Indication and Sales Channel

• 8.1. Definition and Scope
• 8.2. Regional Market Share Analysis, 2023 & 2030
• 8.3. Regional Market Dashboard
• 8.4. Regional Market Snapshot
• 8.5. SWOT Analysis
  • 8.5.1. North America
  • 8.5.2. Europe
  • 8.5.3. Asia Pacific
  • 8.5.4. Latin America
  • 8.5.5. Middle East & Africa
• 8.6. Parenteral Nutrition Market Share, By Region, 2023 & 2030 (USD Billion)
• 8.7. North America
  • 8.7.1. North America Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.7.2. U.S.
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Regulatory Landscape/Reimbursement Scenario
    • 8.7.2.3. Competitive Insights
    • 8.7.2.4. U.S. Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.7.3. Canada
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Regulatory Landscape/Reimbursement Scenario
    • 8.7.3.3. Competitive Insights
    • 8.7.3.4. Canada Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 8.8. Europe
  • 8.8.1. Europe Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.8.2. UK
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.2.3. Competitive Insights
    • 8.8.2.4. UK Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.8.3. Germany
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.3.3. Competitive Insights
    • 8.8.3.4. Germany Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.8.4. France
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.4.3. Competitive Insights
    • 8.8.4.4. France Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.8.5. Italy
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.5.3. Competitive Insights
    • 8.8.5.4. Italy Parenteral Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.8.6. Spain
    • 8.8.6.1. Key Country Dynamics
    • 8.8.6.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.6.3. Competitive Insights
    • 8.8.6.4. Spain Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.8.7. Sweden
    • 8.8.7.1. Key Country Dynamics
    • 8.8.7.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.7.3. Competitive Insights
    • 8.8.7.4. Sweden Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.8.8. Denmark
    • 8.8.8.1. Key Country Dynamics
    • 8.8.8.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.8.3. Competitive Insights
    • 8.8.8.4. Denmark Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.8.9. Norway
    • 8.8.9.1. Key Country Dynamics
    • 8.8.9.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.9.3. Competitive Insights
    • 8.8.9.4. Norway Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 8.9. Asia Pacific
  • 8.9.1. Asia Pacific Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.9.2. China
    • 8.9.2.1. Key Country Dynamics
    • 8.9.2.2. Regulatory Landscape/Reimbursement Scenario
    • 8.9.2.3. Competitive Insights
    • 8.9.2.4. China Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.9.3. Japan
    • 8.9.3.1. Key Country Dynamics
    • 8.9.3.2. Regulatory Landscape/Reimbursement Scenario
    • 8.9.3.3. Competitive Insights
    • 8.9.3.4. Japan Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.9.4. India
    • 8.9.4.1. Key Country Dynamics
    • 8.9.4.2. Regulatory Landscape/Reimbursement Scenario
    • 8.9.4.3. Competitive Insights
    • 8.9.4.4. India Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.9.5. South Korea
    • 8.9.5.1. Key Country Dynamics
    • 8.9.5.2. Regulatory Landscape/Reimbursement Scenario
    • 8.9.5.3. Competitive Insights
    • 8.9.5.4. South Korea Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.9.6. Australia
    • 8.9.6.1. Key Country Dynamics
    • 8.9.6.2. Regulatory Landscape/Reimbursement Scenario
    • 8.9.6.3. Competitive Insights
    • 8.9.6.4. Australia Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.9.7. Thailand
    • 8.9.7.1. Key Country Dynamics
    • 8.9.7.2. Regulatory Landscape/Reimbursement Scenario
    • 8.9.7.3. Competitive Insights
    • 8.9.7.4. Thailand Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 8.10. Latin America
  • 8.10.1. Latin America Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.10.2. Brazil
    • 8.10.2.1. Key Country Dynamics
    • 8.10.2.2. Regulatory Landscape/Reimbursement Scenario
    • 8.10.2.3. Competitive Insights
    • 8.10.2.4. Brazil Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.10.3. Mexico
    • 8.10.3.1. Key Country Dynamics
    • 8.10.3.2. Regulatory Landscape/Reimbursement Scenario
    • 8.10.3.3. Competitive Insights
    • 8.10.3.4. Mexico Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.10.4. Argentina
    • 8.10.4.1. Key Country Dynamics
    • 8.10.4.2. Regulatory Landscape/Reimbursement Scenario
    • 8.10.4.3. Competitive Insights
    • 8.10.4.4. Argentina Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 8.11. Middle East and Africa
  • 8.11.1. Middle East and Africa Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.11.2. Saudi Arabia
    • 8.11.2.1. Key Country Dynamics
    • 8.11.2.2. Regulatory Landscape/Reimbursement Scenario
    • 8.11.2.3. Competitive Insights
    • 8.11.2.4. Saudi Arabia Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.11.3. UAE
    • 8.11.3.1. Key Country Dynamics
    • 8.11.3.2. Regulatory Landscape/Reimbursement Scenario
    • 8.11.3.3. Competitive Insights
    • 8.11.3.4. UAE Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.11.4. South Africa
    • 8.11.4.1. Key Country Dynamics
    • 8.11.4.2. Regulatory Landscape/Reimbursement Scenario
    • 8.11.4.3. Competitive Insights
    • 8.11.4.4. South Africa Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.11.5. Kuwait
    • 8.11.5.1. Key Country Dynamics
    • 8.11.5.2. Regulatory Landscape/Reimbursement Scenario
    • 8.11.5.3. Competitive Insights
    • 8.11.5.4. Kuwait Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis by Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Market Share Analysis
• 9.4. Company Heat Map Analysis
• 9.5. Strategy Mapping
  • 9.5.1. Expansion
  • 9.5.2. Mergers & Acquisition
  • 9.5.3. Partnerships & Collaborations
  • 9.5.4. New Product Launches
  • 9.5.5. Research And Development
• 9.6. Company Profiles
  • 9.6.1. Baxter
    • 9.6.1.1. Company Overview
    • 9.6.1.2. Financial Performance
    • 9.6.1.3. Product Benchmarking
    • 9.6.1.4. Strategic initiatives
  • 9.6.2. Allergan
    • 9.6.2.1. Company Overview
    • 9.6.2.2. Financial Performance
    • 9.6.2.3. Product Benchmarking
    • 9.6.2.4. Strategic initiatives
  • 9.6.3. Actavis Inc.
    • 9.6.3.1. Company Overview
    • 9.6.3.2. Financial Performance
    • 9.6.3.3. Product Benchmarking
    • 9.6.3.4. Strategic initiatives
  • 9.6.4. Otsuka Pharmaceutical Factory, Inc.
    • 9.6.4.1. Company Overview
    • 9.6.4.2. Financial Performance
    • 9.6.4.3. Product Benchmarking
    • 9.6.4.4. Strategic initiatives
  • 9.6.5. Grifols, S.A.
    • 9.6.5.1. Company Overview
    • 9.6.5.2. Financial Performance
    • 9.6.5.3. Product Benchmarking
    • 9.6.5.4. Strategic initiatives
  • 9.6.6. B. Braun Melsungen AG
    • 9.6.6.1. Company Overview
    • 9.6.6.2. Financial Performance
    • 9.6.6.3. Product Benchmarking
    • 9.6.6.4. Strategic initiatives
  • 9.6.7. Vifor Pharma
    • 9.6.7.1. Company Overview
    • 9.6.7.2. Financial Performance
    • 9.6.7.3. Product Benchmarking
    • 9.6.7.4. Strategic initiatives
  • 9.6.8. Fresenius Kabi AG
    • 9.6.8.1. Company Overview
    • 9.6.8.2. Financial Performance
    • 9.6.8.3. Product Benchmarking
    • 9.6.8.4. Strategic initiatives
  • 9.6.9. Sichuan Kelun Pharmaceutical Co., Ltd
    • 9.6.9.1. Company Overview
    • 9.6.9.2. Financial Performance
    • 9.6.9.3. Product Benchmarking
    • 9.6.9.4. Strategic initiatives
  • 9.6.10. Pfizer Inc. (Hospira Inc.)
    • 9.6.10.1. Company Overview
    • 9.6.10.2. Financial Performance
    • 9.6.10.3. Product Benchmarking
    • 9.6.10.4. Strategic initiatives